207 related articles for article (PubMed ID: 38500385)
1. Shaping the immune-suppressive microenvironment on tumor-associated myeloid cells through tumor-derived exosomes.
Wang H; Liu S; Zhan J; Liang Y; Zeng X
Int J Cancer; 2024 Jun; 154(12):2031-2042. PubMed ID: 38500385
[TBL] [Abstract][Full Text] [Related]
2. Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment.
Tian X; Shen H; Li Z; Wang T; Wang S
J Hematol Oncol; 2019 Aug; 12(1):84. PubMed ID: 31438991
[TBL] [Abstract][Full Text] [Related]
3. Biophysical heterogeneity of myeloid-derived microenvironment to regulate resistance to cancer immunotherapy.
Zhao J; Dong Y; Zhang Y; Wang J; Wang Z
Adv Drug Deliv Rev; 2022 Dec; 191():114585. PubMed ID: 36273512
[TBL] [Abstract][Full Text] [Related]
4. Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral γδ T cell equilibrium via tumor-derived exosomes.
Li L; Cao B; Liang X; Lu S; Luo H; Wang Z; Wang S; Jiang J; Lang J; Zhu G
Oncogene; 2019 Apr; 38(15):2830-2843. PubMed ID: 30546089
[TBL] [Abstract][Full Text] [Related]
5. Exosome-Mediated Immunosuppression in Tumor Microenvironments.
Xie QH; Zheng JQ; Ding JY; Wu YF; Liu L; Yu ZL; Chen G
Cells; 2022 Jun; 11(12):. PubMed ID: 35741075
[TBL] [Abstract][Full Text] [Related]
6. The immunomodulatory role of exosomal microRNA networks in the crosstalk between tumor-associated myeloid-derived suppressor cells and tumor cells.
Shokati E; Safari E
Int Immunopharmacol; 2023 Jul; 120():110267. PubMed ID: 37276829
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Derived Exosomes in Immunosuppression and Immunotherapy.
Olejarz W; Dominiak A; Żołnierzak A; Kubiak-Tomaszewska G; Lorenc T
J Immunol Res; 2020; 2020():6272498. PubMed ID: 32537468
[TBL] [Abstract][Full Text] [Related]
8. Roles of the Exosomes Derived From Myeloid-Derived Suppressor Cells in Tumor Immunity and Cancer Progression.
Chen Z; Yuan R; Hu S; Yuan W; Sun Z
Front Immunol; 2022; 13():817942. PubMed ID: 35154134
[TBL] [Abstract][Full Text] [Related]
9. The Role of Tumor-Derived Exosomes (TEX) in Shaping Anti-Tumor Immune Competence.
Whiteside TL
Cells; 2021 Nov; 10(11):. PubMed ID: 34831276
[TBL] [Abstract][Full Text] [Related]
10. Myeloid derived suppressor cells and innate immune system interaction in tumor microenvironment.
Pramanik A; Bhattacharyya S
Life Sci; 2022 Sep; 305():120755. PubMed ID: 35780842
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated macrophages derived exosomes; from pathogenesis to therapeutic opportunities.
Hadad S; Khalaji A; Sarmadian AJ; Sarmadian PJ; Janagard EM; Baradaran B
Int Immunopharmacol; 2024 Jul; 136():112406. PubMed ID: 38850795
[TBL] [Abstract][Full Text] [Related]
12. Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts.
Khan NA; Asim M; Biswas KH; Alansari AN; Saman H; Sarwar MZ; Osmonaliev K; Uddin S
J Exp Clin Cancer Res; 2023 Aug; 42(1):221. PubMed ID: 37641132
[TBL] [Abstract][Full Text] [Related]
13. The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells.
Wang J; De Veirman K; De Beule N; Maes K; De Bruyne E; Van Valckenborgh E; Vanderkerken K; Menu E
Oncotarget; 2015 Dec; 6(41):43992-4004. PubMed ID: 26556857
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated myeloid cells: new understandings on their metabolic regulation and their influence in cancer immunotherapy.
Porta C; Sica A; Riboldi E
FEBS J; 2018 Feb; 285(4):717-733. PubMed ID: 28985035
[TBL] [Abstract][Full Text] [Related]
15. Theranostic signature of tumor-derived exosomes in cancer.
Kumar S; Dhar R; Kumar LBSS; Shivji GG; Jayaraj R; Devi A
Med Oncol; 2023 Oct; 40(11):321. PubMed ID: 37798480
[TBL] [Abstract][Full Text] [Related]
16. Targeting Myeloid-Derived Suppressor Cells to Enhance the Antitumor Efficacy of Immune Checkpoint Blockade Therapy.
Li X; Zhong J; Deng X; Guo X; Lu Y; Lin J; Huang X; Wang C
Front Immunol; 2021; 12():754196. PubMed ID: 35003065
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Related Exosomes Contribute to Tumor-Promoting Microenvironment: An Immunological Perspective.
Chen W; Jiang J; Xia W; Huang J
J Immunol Res; 2017; 2017():1073947. PubMed ID: 28642882
[TBL] [Abstract][Full Text] [Related]
18. Exosomes in Cancer: Another Mechanism of Tumor-Induced Immune Suppression.
Whiteside TL
Adv Exp Med Biol; 2017; 1036():81-89. PubMed ID: 29275466
[TBL] [Abstract][Full Text] [Related]
19. Exosomes as mediators of immune regulation and immunotherapy in cancer.
Kugeratski FG; Kalluri R
FEBS J; 2021 Jan; 288(1):10-35. PubMed ID: 32910536
[TBL] [Abstract][Full Text] [Related]
20. Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo.
Chen Z; You L; Wang L; Huang X; Liu H; Wei JY; Zhu L; Qian W
J Exp Clin Cancer Res; 2018 Aug; 37(1):190. PubMed ID: 30103789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
